Only an Aβ-producing murine model crossed with Lrp1-/- mice, without a tau protein gene mutation, resulting in the secondary accumulation of tau protein, would be a proper model to evaluate the exact role of LRP1 in the pathology of Alzheimer’s disease. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.